From the CEC Smart Brief:
A Food and Drug Administration pediatric advisory committee recommended Wednesday that Ritalin and other drugs used to treat ADHD contain a warning about potential cardiovascular and psychiatric risks, but not the strongest possible "black-box" caution that an FDA drug safety advisory committee in February had called for. The FDA has not found a definitive link between the drugs and reported psychiatric events in users. Canada.com/Canadian Press (3/23)
No comments:
Post a Comment